University of Oxford

🇬🇧United Kingdom

Country: 🇬🇧United Kingdom

Ownership: Private

Established: 1096-01-01

Employees: 10K

Market Cap: -

Website: http://www.ox.ac.uk

Clinical Trials

Safety and Immunogenicity of Pvs25-IMX313/Matrix-M1 Vaccine

Early Phase 1

Terminated

Conditions: Malaria, Vivax

Interventions: Biological: Pvs25-IMX313/Matrix-M1

First Posted Date: 2022-03-08

Last Posted Date: 2024-08-09

Lead Sponsor: University of Oxford

Target Recruit Count: 25

Registration Number: NCT05270265

Locations: 🇬🇧
CCVTM, University of Oxford, Churchill Hospital, Oxford, United Kingdom

Fluid Restriction and Quality of Life on Dialysis

Not Applicable

Completed

Conditions: End Stage Renal Disease

Interventions: Behavioral: ACT Matrix

First Posted Date: 2022-03-03

Last Posted Date: 2022-12-08

Lead Sponsor: University of Oxford

Target Recruit Count: 8

Registration Number: NCT05264220

Locations: 🇬🇧
Renal and Transplant Medicine Unit (and satellite units), Oxford University Hospitals NHS Foundation Trust, Oxford, Oxfordshire, United Kingdom

Oxford - Fibrates in Aortic Stenosis

Not Applicable

Conditions: Aortic Valve Stenosis

Interventions: Drug: Fenofibrate Capsules
Drug: Placental Lactogen

First Posted Date: 2022-02-25

Last Posted Date: 2022-02-25

Lead Sponsor: University of Oxford

Target Recruit Count: 67

Registration Number: NCT05256758

Locations: 🇬🇧
OUH NHS trust, Oxford, United Kingdom

PARADISE: Predicting AF After Cardiac Surgery

Active, not recruiting

Conditions: Atrial Fibrillation New Onset

Interventions: Other: Not applicable as observational study

First Posted Date: 2022-02-24

Last Posted Date: 2024-08-14

Lead Sponsor: University of Oxford

Target Recruit Count: 13684

Registration Number: NCT05255224

Locations: 🇬🇧
Critical Care Research Group, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, Oxfordshire, United Kingdom

Safety and Immunogenicity of the Malaria Vaccine, R21/MatrixM, in Healthy Thai Adults

Phase 2

Completed

Conditions: Malaria,Falciparum

Interventions: Biological: R21/Matrix-M vaccination
Drug: DHA-PIP
Drug: PQ

First Posted Date: 2022-02-23

Last Posted Date: 2023-10-27

Lead Sponsor: University of Oxford

Target Recruit Count: 127

Registration Number: NCT05252845

Locations: 🇹🇭
Hospital for Tropical Diseases, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand

Remote By Default 2: Optimising the Remote-by-default Model in the United Kingdom (UK) General Practice

Conditions: COVID-19

First Posted Date: 2022-02-17

Last Posted Date: 2022-04-06

Lead Sponsor: University of Oxford

Target Recruit Count: 40

Registration Number: NCT05244941

Locations: 🇬🇧
University of Oxford, Oxford, United Kingdom

Tracking Atrial Fibrillation After Intensive Care Admission

Recruiting

Conditions: Atrial Fibrillation
Atrial Fibrillation New Onset
New Onset Atrial Fibrillation

Interventions: Device: Cardiac monitoring

First Posted Date: 2022-02-08

Last Posted Date: 2024-06-17

Lead Sponsor: University of Oxford

Target Recruit Count: 100

Registration Number: NCT05229211

Locations: 🇬🇧
Oxford University Hospitals Trust, Oxford, Oxfordshire, United Kingdom

Prucalopride and Cognition in Recovered Depression

Not Applicable

Completed

Conditions: Depression in Remission

Interventions: Drug: Prucalopride
Drug: Placebo

First Posted Date: 2022-02-02

Last Posted Date: 2024-02-09

Lead Sponsor: University of Oxford

Target Recruit Count: 50

Registration Number: NCT05220228

Locations: 🇬🇧
Department of Psychiatry, Warneford Hospital, University of Oxford, Oxford, Oxfordshire, United Kingdom

MotIoN aDaptive Deep Brain Stimulation for MSA

Not Applicable

Recruiting

Conditions: MSA - Multiple System Atrophy

Interventions: Device: Deep brain stimulation

First Posted Date: 2022-01-20

Last Posted Date: 2024-04-10

Lead Sponsor: University of Oxford

Target Recruit Count: 5

Registration Number: NCT05197816

Locations: 🇬🇧
John Radcliffe Hospital, Oxford, Oxfordshire, United Kingdom

The TRANSLATE Trial

Not Applicable

Conditions: Prostate Cancer

Interventions: Diagnostic Test: Prostate biopsy

First Posted Date: 2022-01-05

Last Posted Date: 2022-01-05

Lead Sponsor: University of Oxford

Target Recruit Count: 1042

Registration Number: NCT05179694

Locations: 🇬🇧
Department of Urology, Oxford University Hospitals NHS Foundation Trust, Oxford, Oxfordshire, United Kingdom

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy